These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38980402)

  • 1. Sex/gender differences in spontaneous reports to a French Addictovigilance centre.
    Peyriére H; Dampierre A; Vallo R; Lestienne M; Eiden C; Donnadieu H
    Arch Womens Ment Health; 2024 Jul; ():. PubMed ID: 38980402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addictovigilance in women, the hidden part of the iceberg?
    Lapeyre-Mestre M
    Therapie; 2023; 78(2):157-164. PubMed ID: 36280399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health consequences of cocaine use in France: data from the French Addictovigilance Network.
    Eiden C; Vincent M; Serrand C; Serre A; Richard N; Picot MC; Frauger E; Fouilhé N; Daveluy A; Peyrière H;
    Fundam Clin Pharmacol; 2021 Apr; 35(2):455-465. PubMed ID: 32854152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addictovigilance contribution during COVID-19 epidemic and lockdown in France.
    Lapeyre-Mestre M; Boucher A; Daveluy A; Gibaja V; Jouanjus E; Mallaret M; Peyrière H; Micallef J;
    Therapie; 2020; 75(4):343-354. PubMed ID: 32660776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020.
    Diaz L; Eiden C; Jouanjus E; Frauger E; Fouilhé N; Djezzar S; Gibaja V; Boucher A; Le Boisselier R; Libert F; Caous AS; Monzon E; Guerlais M; Daveluy A; Fauconneau B; Peyrière H
    Therapie; 2023; 78(6):647-657. PubMed ID: 36918317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network?
    Gentile G; Jego M; Spadari M; Griffiths K; Jouanjus E; Micallef J
    Fundam Clin Pharmacol; 2018 Dec; 32(6):643-651. PubMed ID: 30003596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health].
    Micallef J; Jouanjus É; Mallaret M; Lapeyre Mestre M
    Therapie; 2019 Dec; 74(6):579-590. PubMed ID: 31694770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of new psychoactive substances to mimic prescription drugs: The trend in France.
    Batisse A; Eiden C; Peyriere H; Djezzar S;
    Neurotoxicology; 2020 Jul; 79():20-24. PubMed ID: 32240674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical complications of psychoactive substances with abuse risks: Detection and assessment by the network of French addictovigilance centres.
    Peyrière H; Eiden C; Mallaret M; Victorri-Vigneau C
    Therapie; 2016 Dec; 71(6):563-573. PubMed ID: 27499243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal identification in addictovigilance: the functioning of the French system.
    Jouanjus E; Gibaja V; Kahn JP; Haramburu F; Daveluy A
    Therapie; 2015; 70(2):113-31. PubMed ID: 25858567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.
    Tambon M; Ponté C; Jouanjus E; Fouilhé N; Micallef J; Lapeyre-Mestre M;
    Front Psychiatry; 2021; 12():639780. PubMed ID: 33613345
    [No Abstract]   [Full Text] [Related]  

  • 12. [Involvement of addictovigilance in emergency department for the detection of abuse and dependence cases: 3 years of experience].
    Serre A; Eiden C; Gourhant V; Laureau M; Perier D; Giraud I; Sebbane M; Peyrière H
    Therapie; 2018 Dec; 73(6):501-509. PubMed ID: 30017376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrous oxide: a unique official French addictovigilance national survey.
    Guerlais M; Aquizerate A; Lionnet A; Daveluy A; Duval M; Gérardin M; Istvan M; Laforgue EJ; Victorri-Vigneau C;
    Front Public Health; 2023; 11():1167746. PubMed ID: 37206871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of abuse/dependence cases by the French addictovigilance network (FAN): A pilot study of the addictovigilance center and the psychotherapeutic center of Nancy (France)].
    Barberot P; Gibaja V; Benkhedda C; Dobre D; Tournebize J; Kahn JP
    Therapie; 2019 Jun; 74(3):389-397. PubMed ID: 30392700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemsex practice in France: An update in Addictovigilance data.
    Batisse A; Eiden C; Deheul S; Monzon E; Djezzar S; Peyrière H
    Fundam Clin Pharmacol; 2022 Apr; 36(2):397-404. PubMed ID: 34494320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of psychostimulants in a sexual context: Analysis of cases reported to the French network of Addictovigilance Centers].
    Batisse A; Peyrière H; Eiden C; Courné MA; Djezzar S;
    Therapie; 2016 Oct; 71(5):447-455. PubMed ID: 27203172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in driving under the influence of psychoactive drugs: Evidence mapping of real case studies and meta-analysis.
    Pelletti G; Boscolo-Berto R; Barone R; Giorgetti A; Fiorentini C; Pascali JP; Fais P; Pelotti S
    Forensic Sci Int; 2022 Dec; 341():111479. PubMed ID: 36279739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid poisoning cases aged 50+ in the 2015-2020 National Poisoning Data System: suspected suicides versus unintentional poisoning and other intentional misuse/abuse.
    Choi NG; Choi BY; DiNitto DM; Marti CN; Baker SD
    Drug Chem Toxicol; 2022 Nov; 45(6):2706-2717. PubMed ID: 34607473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020.
    Bouquet E; Eiden C; Fauconneau B; Pion C; ; Pain S; Pérault-Pochat MC
    Sci Rep; 2022 Oct; 12(1):16509. PubMed ID: 36192621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data.
    Roussin A; Soeiro T; Fouque C; Jouanjus E; Frauger E; Fouilhé N; Mallaret M; Micallef J; Lapeyre-Mestre M;
    Br J Clin Pharmacol; 2022 Aug; 88(8):3789-3802. PubMed ID: 35318713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.